Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 6
Review
Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,548 | Dovepress* | 10,201+ | 2,080 | 12,281 | |
| PubMed Central* | 2,347 | 1,024 | 3,371 | ||
| Totals | 12,548 | 3,104 | 15,652 | ||
|
*Since 5 August 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar